SEARCH

SEARCH BY CITATION

References

  • Aboukasm AG, Smith BJ. (1997) Nocturnal vertebral compression fracture. A presenting feature of unrecognized epileptic seizures. Arch Fam Med 6:185187.
  • Ali II, Schuh L, Barkley GL, Gates JR. (2004) Antiepileptic drugs and reduced bone mineral density. Epilepsy Behav 5:296300.
  • Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W. (2002) Antiepileptic drug–induced bone loss in young male patients who have seizures. Arch Neurol 59:781786.
  • Binkley N, Krueger D, Gangnon R, Genant HK, Drezner MK. (2005) Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures. Osteoporos Int 16:15131518.
  • Boonen S, Orwoll ES, Wenderoth D, Stoner KJ, Eusebio R, Delmas PD. (2009) Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. J Bone Miner Res 24:719725.
  • Buns L. (2013) Osteoporosis in veterans with chronic alcohol use: an early recognition and treatment program. Fed Pract 30:2531.
  • Carbone LD, Johnson KC, Robbins J, Larson JC, Curb JD, Watson K, Gass M, Lacroix AZ. (2010) Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI). J Bone Miner Res 25:873881.
  • Chung S, Ahn C. (1994) Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev 16:382385.
  • Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM. (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767773.
  • Damilakis J, Adams J, Guglielmi G, Link T. (2010) Radiation exposure in X-ray-based imaging techniques used in osteoporosis. Eur Radiol 20:27072714.
  • Dent CE, Richens A, Rowe DJ, Stamp TC. (1970) Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J 4:6972.
  • Duboeuf F, Bauer DC, Chapurlat RD, Dinten JM, Delmas P. (2005) Assessment of vertebral fracture using densitometric morphometry. J Clin Densitom 8:362368.
  • Ensrud KE, Walczak TS, Blackwell T, Ensrud ER, Bowman PJ, Stone KL. (2004) Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 62:20512057.
  • Ensrud KE, Walczak TS, Blackwell TL, Ensrud ER, Barrett-Connor E, Orwoll ES. (2008) Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology 71:723730.
  • Espinosa PS, Perez DL, Abner E, Ryan M. (2011) Association of antiepileptic drugs, vitamin D, and calcium supplementation with bone fracture occurrence in epilepsy patients. Clin Neurol Neurosurg 113:548551.
  • Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58:13481353.
  • Gidal BE, Sheth RD. (2004) Epilepsy and bone health: is there cause for concern? Epilepsy Behav 5:12.
  • Hind K, Oldroyd B, Truscott JG. (2010) In vivo precision of the GE Lunar iDXA densitometer for the measurement of total-body, lumbar spine, and femoral bone mineral density in adults. J Clin Densitom 13:413417.
  • Holmberg AH, Johnell O, Nilsson PM, Nilsson J, Berglund G, Akesson K. (2006) Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 17:10651077.
  • Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E. (2009) FRAX and its applications to clinical practice. Bone 44:734743.
  • Krege JH, Miller PD, Lenchik L, Misurski DA, Chen P. (2006) New or worsening lumbar spine vertebral fractures increase lumbar spine bone mineral density and falsely suggest improved skeletal status. J Clin Densitom 9:144149.
  • Kruse R. (1968) Osteopathies in antiepileptic long-term therapy (preliminary report). Monatsschr Kinderheilkd 116:378381.
  • Lee RH, Lyles KW, Colón-Emeric C. (2010) A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother 8:3446.
  • Little EA, Eccles MP. (2010) A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. Implement Sci 5:80.
  • Lotfizadeh HTM, Montouris G. (2004) Bone health in males with epilepsy. Scientific Meeting American Society of Epilepsy, New Orleans, LA.
  • Majumdar SR, Lier DA, McAlister FA, Rowe BH, Siminoski K, Hanley DA, Russell AS, Johnson JA. (2013) Cost-effectiveness of osteoporosis interventions for ‘incidental’ vertebral fractures. Am J Med 126:169.e169169.e117.
  • Mattson RH, Gidal BE. (2004) Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav 5(Suppl. 2):S36S40.
  • McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM. (2013) Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med 126:1320.
  • Mikati MA, Dib L, Yamout B, Sawaya R, Rahi AC, Fuleihan Gel-H. (2006) Two randomized vitamin D trials in ambulatory patients on anticonvulsants. Impact on bone. Neurology 67:20042014.
  • National Osteoporosis Foundation. (2013) Clinician's guide to prevention and treatment of osteoporosis. In Foundation NO (Ed.). National Osteoporosis Foundation, Washington, DC.
  • Nilsson OS, Lindholm TS, Elmstedt E, Lindback A, Lindholm TC. (1986) Fracture incidence and bone disease in epileptics receiving long-term anticonvulsant drug treatment. Arch Orthop Trauma Surg 105:146149.
  • O'Hare JA, Duggan B, O'Driscoll D, Callaghan N. (1980) Biochemical evidence for osteomalacia with carbamazepine therapy. Acta Neurol Scand 62:282286.
  • Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A. (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604610.
  • Pack AM, Morrell MJ. (2004) Epilepsy and bone health in adults. Epilepsy Behav 5(Suppl. 2):S24S29.
  • Persson HB, Alberts KA, Farahmand BY, Tomson T. (2002) Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia 43:768772.
  • Ringe JD, Farahmand P, Faber H, Dorst A. (2009) Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Rheumatol Int 29:311315.
  • Robinson PJ, Bell RJ, Lanzafame A, Segal L, Kirby C, Piterman L, Davis SR. (2013) Comparison of plain vertebral X-ray and dual-energy X-ray absorptiometry for the identification of older women for fracture prevention in primary care. Intern Med J 43:3845.
  • Sato YK, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K. (2001) Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 57:445449.
  • Sheth RD, Wesolowski CA, Jacob JC, Penney S, Hobbs GR, Riggs JE, Bodensteiner JB. (1995) Effect of carbamazepine and valproate on bone mineral density. J Pediatr 127:256262.
  • Sheth RD, Gidal BE, Hermann BP. (2006) Pathological fractures in epilepsy. Epilepsy Behav 9:601605.
  • Stephen LJ, McLellan AR, Harrison JH, Shapiro D, Dominiczak MH, Sills GJ, Brodie MJ. (1999) Bone density and antiepileptic drugs: a case–controlled study. Seizure 8:339342.
  • Vestergaard P. (2005) Epilepsy, osteoporosis and fracture risk – a meta-analysis. Acta Neurol Scand 112:277286.
  • Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L. (1999) Fracture risk is increased in epilepsy. Acta Neurol Scand 99:269275.
  • Vestergaard P, Rejnmark L, Mosekilde L. (2004) Fracture risk associated with use of antiepileptic drugs. Epilepsia 45:13301337.
  • Weiss HJ. (1996) QM for Windows Version 1.41.